Inventor

SCHOENTJES BRUNO

FR25 patents

⚠️ This page may combine multiple inventors who share the name “SCHOENTJES BRUNO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

SCHOENTJES BRUNO

JANSSEN PHARMACEUTICA NV

Inhibitors of the interaction between MDM2 and p53

Substituted diaza-spiro-[5.5]-undecane derivatives and their use as neurokinin antagonists

Inhibitors of the interaction between MDM2 and P53

Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and P53

Substituted diaza-spiro-[4.5]-decane derivatives and their use as neurokinin antagonists

Benzocycloheptane and benzoxepine derivatives

Macrocylic pyrimidine derivatives

SANOFI AVENTIS

Phenylsulfonyl-1,3-dihydro-2h-indole-2-one derivatives, their preparation and their therapeutic use

Acylaminothiazole derivatives, their preparation and their therapeutic use

Acylaminothiazole derivatives, preparation and therapeutic use thereof

Use of acylaminothiazole derivatives as therapeutic agents

Therapeutic use of acylaminothiazole derivatives

SCHOENTJES BRUNO

Benzocycloheptane and benzoxepine derivatives

Benzocycloheptane and benzoxepine derivatives

Indole derivatives as anticancer agents

LACRAMPE JEAN FERNAND ARMAND

Inhibitors of the interaction between MDM2 and P53

Cyclic-alkylamine derivatives as inhibitors of the interaction between MDM2 and p53

SANOFI SYNTHELABO

1,3-dihydro-2H-indol-2-one derivatives, preparation method and pharmaceutical composition containing them

STORCK PIERRE-HENRI

Inhibitors of the interaction between MDM2 and p53

LACRAMPE JEAN FERAND ARMAND

Inhibitors of the interaction between MDM2 and P53

JENSSENS FRANS EDUARD

Substituted oxa-diaza-spiro-[5.5]-undecanone derivatives and their use as neurokinin antagonists

PONCELET VIRGINIE SOPHIE

Inhibitors of the interaction between MDM2 and P53

PONCELET ALAIN PHILIPPE

Substituted phenylenediamines as inhibitors of the interaction between MDM2 and P53

VALORE

Composition comprising a complex of (+)-catechin and amino acid for the treatment and prevention of cancer

JANSSENS FRANS EDUARD

Diaza-spiro-{4,4}-nonane derivatives as neurokinin (NK1) antagonists